Exopten Shows Promise in Spinal Cord Injury Recovery
NurExone Biologic Inc. has successfully completed a preclinical study of its ExoPTEN treatment for spinal cord injuries, demonstrating significant...
Jon Napitupulu
Gradalis Unveils Clonal Tumor Mutation Burden Pipeline
Gradalis, a clinical-stage biotech company, published a peer-reviewed article in Scientific Reports detailing their novel exome sequencing procedure and...
KRRO-110 FDA Orphan Drug Designation for A1AD Deficiency
Korro Bio announced that its investigational medicine, KRRO-110, received orphan drug designation from the FDA for treating Alpha-1 Antitrypsin...
Gain Therapeutics Doses First Patient in Phase 1b Parkinson’s Trial
Gain Therapeutics has dosed the first Parkinson’s disease patient in a Phase 1b clinical trial of its lead candidate,...
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
Eton Pharmaceuticals announced positive results from a bioequivalence study of ET-600, its patented oral solution of desmopressin for central...
FDA Approves Expanded Label for Iluvien®
ANI Pharmaceuticals received FDA approval for an expanded label for ILUVIEN, adding chronic non-infectious uveitis affecting the posterior segment...
Avextra Cannabis Sleep Study 2025 Findings
Avextra’s IMPACT study reveals that its Cannabis Extract 10:10 significantly improved sleep quality and reduced pain in chronic pain...
Dyne-251 Shows Unprecedented Functional Improvement in DMD Trial
Dyne Therapeutics announced positive long-term clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy...
EnnoDC Presents Positive Phase I AMV Data at CROI 2025
EnnoDC’s Phase I ANRS VRI06 trial demonstrated that its Antibody Mediated Vaccine (AMV) technology induces a safe, durable, and...
BioAdaptives Zeranovia Weight Loss Dosage Trial Shows Promise
BioAdaptives, Inc. (OTC: BDPT) has completed dosage trials for its weight loss product, Zeranovia™, showing significant weight loss (5-7...